As a licensed provider in both New Jersey and New York, we are proud to offer doorstep delivery of our medications
Recent clinical trials (OASIS 1 and OASIS 4) show that the new higher-dose oral semaglutide tablets (25 mg and 50 mg) are just as effective as the traditional 2.4 mg injection, delivering an average weight loss of 14% to 17% over 64 to 68 weeks
InThought: Takeda is positioning the drug as a first-in-class disease- modifying therapy for narcolepsy type 1 (NT1), directly addressing orexin deficiency rather than merely managing symptoms
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S
Medical Review BoardMedical Review BoardExpert AnswerYes, usually the entire needle is submerged under the skin
If you experience any discomfort during use